Latest Press Release on drugs

1-800-GOT-MOLD?’s Dog Detectives Have a Leg Up on the Competition
PRINCETON, N.J. - Used throughout human history to locate everything from bombs and drugs to missing persons, canines are now being utilized to detect potentially lethal

---

Cambridge-based Ligon Discovery Raises $1M in Seed Funding
CAMBRIDGE, Mass., Nov. 19 /PRNewswire/ -- Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced that it has raised $1M in seed financing led by incTANK Ventures. The company will use the capital to co...

---

AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference
BOTHELL, WA -- 11/19/09 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced presentations on the company's exon skipping therapy for Duchenne muscular dystrophy at the TREAT-NMD / NIH International Conference taki..

---

OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
MELVILLE, N.Y. - OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that the Oncologic Drugs Advisory Committee (ODAC) will review the use of Tarceva® (erlotinib) as a first-line maintenance therapy for patients with advanced non-small cell lung cancer (NSCLC) who have n

---

Potent Anti-tumor PARP Inhibitor Discovered by LEAD Therapeutics
SAN BRUNO, Calif. & SHANGHAI - LEAD Therapeutics, a privately held drug discovery company, today announced the discovery of a novel, orally available, PARP inhibitor with potent anti-tumor activity both as single-agent treatment and in combination with chemotherapy drugs. The new compoun

---

Lotus Pharmaceuticals, Inc. Reports Third-Quarter 2009 Results
BEIJING, Nov. 16 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical pr...

---

Sinobiopharma has Production Rights to 23 Drugs Listed in China's National Essential Drugs List
NANTONG, China, Nov. 16 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. ("Sinobiopharma" or, the "Company") (OTC Bulletin Board: SNBP) is pleased to announce that 23 generic drugs for which the Company has production rights are list...

---

Breaking the News, or Fueling the Epidemic? News Coverage of Opioid-Related Deaths Often Precede an Increase in Deaths, Study Finds
BOSTON, Nov. 18 /PRNewswire-USNewswire/ -- Increases in deaths from opioid drugs such as OxyContin may be linked to the volume of coverage such deaths receive in the news, according to a study from Children's Hospital Boston and the University of North Carolina (UNC), Chapel Hill. The s...

---

instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters
LOS ANGELES, Nov. 18 -- instaCare Corp., (OTC Bulletin Board: ISCR), a leading distributor of life-saving prescription drugs and at-home testing diagnostics for the chronically ill, and a leading developer of patentable technologies for e-pharmacy, e-he...

---

Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases
NEW YORK & GENEVA - Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vu

---

PharmaShack.com Embraces Fall - Offers 15 Percent Off of All Meds on Site
PharmaShack.com - an online pharmacy selling over the counter drugs offers a special fall discount of 15% off on all items, and a new and exciting range of new dietary products such as Hoodia, Mega Hoodia and Acai herbs./I/P P(PRWEB) November 16, 2009 -- It seems that everyone needs med...

---

American Heart Association Late Breaking Clinical Trial Report: Tests Predict Which Patients Are Resistant to Anti-Clotting Therapy During Angioplasty, Stenting
Study highlights: -- Three of six platelet reactivity tests predicted a risk of adverse outcomes related to blood clots in patients receiving two anti-clotting drugs following angioplasty (PCI) plus stenting. -- Three other tests failed to predict excess risk....

---

Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090
LEXINGTON, Mass. - Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Mole

---

Synta Presents New Data on Mechanism of Action of Elesclomol at AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
LEXINGTON, Mass. - Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today presented new data on the mechanism of action of elesclomol, a first-in-class oxid

---

Generic Drugs Just as Effective as Brand Name Drugs Says DoctorSolve
Despite years of controversy, new study finds that generic drugs to be equally as effective as brand name drugs./I/P P(PRWEB) November 19, 2009 -- A recent publication in the October issue of The Medical Letter may help to eliminate the fear many people have about generic drugs. A syste...

---

Latest Trend to Lose Weight: Nutritional Body Cleansing
Most of us are exposed to doctors, hospitals and taught to take prescription medication (drugs) to treat the symptoms of the life illnesses and weight loss. Through the use of natural a href= http://www.cleansingandnutrition.com/ onclick= linkClick( this.href ); target= _blank title= bo...

---

Michael Jackson Propofol Expert, Dr. Barry Friedberg, to Speak in Veracruz
Brain monitoring of Jackson's propofol could have saved his life despite the other drugs in his body. For the second consecutive year, propofol expert, Dr. Barry Friedberg will address the annual Congress of Mexican Anesthesiologists, this year in Veracruz, Mexico. Also, an expert on brain mo...

---

Buy Generic Levitra Online and Avoid Uncomfortable Situations
Convenience, privacy and sometimes drugs at a more affordable price are some major advantages an online pharmacy provides. It’s only a click of a button - the internet provides the convenience of ordering from their bedrooms in complete privacy, helping people who find it embarrassing to order for medicines.

---

Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology
BALTIMORE, Nov. 18 -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclu...

---

AVI BioPharma, Inc. to Present at Transformational Medical Technologies Initiative (TMTI) Industry Day
BOTHELL, WA -- 11/18/09 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Patrick Iversen, Ph.D., Senior Vice President of Strategic Alliances, will present at the upcoming Transformational Medical Technolo..

---

Find Product Liability Lawyers and Legal Information at LawyerCentral.com
(EMAILWIRE.COM, November 18, 2009 ) New York, NY - Lawyer Central has released an updated Product Liability Information Center featuring legal articles about Dangerous Drugs, Defective Medical Devices, and Products Liability Law. It is important for ..

---

Cardinus Supports Road Safety Week Focus on Drink and Drugs
Cardinus Risk Management is backing this year’s Road Safety Week, which is focusing on the theme of drinks and drugs, and endorsing the message from the organisers, road safety charity Brake, for companies to do more in getting the message across to staff about the dangers of driving un...

---

FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations
RIDGEFIELD, Conn. & NEW YORK - The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application (sNDA) provide substantial and convincing evidence to support the claim that SPIRIVA

---